通过核氨酸和小热冲击蛋白复合体调节MDM2-p53连接
bioRxiv : the preprint server for biology
|May 23, 2025
概括
基因毒性压力激活了PIPKIα,产生了与MDM2.2结合的PIP2. 这种相互作用调节了MDM2的稳定性及其与p53的相互作用,为癌症治疗提供了新的策略.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 瘤抑制剂p53对基因组稳定至关重要,在癌症中经常发生突变.
- p53的稳定性是由其与MDM2coprotein的相互作用调节的,MDM2是一种ubiquitin E3结合酶.
- 核氨酸最近已经被证明可以结合和稳定p53.
研究的目的:
- 研究核氨酸在调节MDM2稳定性和功能的作用.
- 阐明基因毒性压力影响MDM2-p53通路的机制.
- 探索针对癌症中MDM2-p53相互作用的新型治疗策略.
主要方法:
- 研究了基因毒性应激对I型酸丁酸盐激酶 (PIPKIα) 和酸丁酸盐4,5-双酸盐 (PIP2) 水平的影响.
- 在基因毒性压力后分析了PIPKIα和PIP2与MDM2的结合.
- 研究了像αB-晶体蛋白 (αBC) 和HSP27这样的小热冲击蛋白 (sHSPs) 对MDM2-PIP2复合物的差异性招募.
- 评估了PIP2结合对MDM2稳定性,无化活性和p53相互作用的影响.
主要成果:
- 基因毒性压力会诱导核PIPKIα和PIP2,它们与MDM2结合.
- 与MDM2结合的PIP2不同调节αBC和HSP27的招募,作为MDM2的开关.
- 这一规则影响了MDM2的稳定性,下游目标,无处不在的活性和与p53.3的相互作用.
- sHSPs在微调MDM2功能和MDM2-p53连接中发挥着积极的,选择性的作用.
结论:
- 核氨基酸为MDM2-PIP2-sHSPs协会赋予了特异性.
- sHSP的差异化参与突显了他们超越被动监护者的积极作用.
- 这些发现为向癌症中MDM2-p53通路提供了一种新的治疗策略.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
36.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Covalently Linked Protein Regulators
7.5K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K


